Quinazolines

Name
Quinazolines
Accession Number
DBCAT000883
Description

Cyclic compounds that include atoms other than carbon in their ring structure.

Drugs
DrugDrug Description
2X-1212X-121 is under investigation in clinical trial NCT03562832 (Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP).
AfatinibAn antineoplastic agent used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations or resistance to platinum-based chemotherapy.
AltanserinAltanserin is a small molecule drug. The usage of the INN stem '-anserin' in the name indicates that Altanserin is a serotonin receptor antagonist. Altanserin is under investigation in clinical...
ApabetaloneApabetalone has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.
ATH434Not Annotated
ATX-914Axt914 is under investigation in clinical trial NCT00417261 (Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.).
AvadomideAvadomide is under investigation in clinical trial NCT02031419 (Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma).
ButanserinButanserin is a small molecule drug. The usage of the INN stem '-anserin' in the name indicates that Butanserin is a serotonin receptor antagonist. Butanserin has a monoisotopic molecular weight...
Carotegrast methylCarotegrast methyl is under investigation in clinical trial NCT03531892 (A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis).
DacomitinibA medication used to treat non small cell lung cancer with EGFR exon 19 deletion of exon 21 L858R substitution.
DoxazosinAn alpha-1 adrenergic receptor used to treat mild to moderate hypertension and urinary obstruction due to benign prostatic hyperplasia.
ElinogrelInvestigated for use/treatment in cardiovascular disorders and myocardial infarction.
ErlotinibAn EGFR tyrosine kinase inhibitor used to treat certain small cell lung cancers or advanced metastatic pancreatic cancers.
GefitinibA tyrosine kinase inhibitor used as first-line therapy to treat non-small cell lung carcinoma (NSCLC) that meets certain genetic mutation criteria.
HalofuginoneFor the treatment of scleroderma, cancer, and restenosis.
IdelalisibAn antineoplastic kinase inhibitor used to treat chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed small lymphocytic lymphoma (SLL).
KetanserinKetanserin has been investigated for the treatment of Septic Shock, Severe Sepsis, and Diabetic Foot Ulcer.
LapatinibAn antineoplastic agent and tyrosine kinase inhibitor used for the treatment of advanced or metastatic HER-positive breast cancer in patients who received prior chemotherapeutic treatments.
LinagliptinA dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus.
MethaqualoneFor the treatment of insomnia, and as a sedative and muscle relaxant.
MetolazoneA thiazide-like diuretic used to treat hypertension.
MK-0249MK0249 has been used in trials studying the treatment of Hypopnea Syndrome, Alzheimer's Disease, Paranoid Schizophrenia, Sleep Apnea, Obstructive, and Excessive Daytime Sleepiness, among others.
MoquizoneMoquizone is a small molecule drug. The usage of the INN stem '-zone' in the name indicates that Moquizone is a anti-inflammatory analgesic, phenylbutazone derivative. Moquizone has a monoisotopic molecular...
PrazosinAn alpha-blocker that causes a decrease in total peripheral resistance and is used to treat hypertension.
SelurampanelSelurampanel has been investigated in Adrenocortical Adenoma and Sarcoma, Endometrial Stromal.
SP-8203SP-8203 has been used in trials studying the treatment of Ischemic Stroke.
TerazosinAn alpha-1 adrenergic antagonist used in the treatment of symptomatic benign prostatic hyperplasia and management of hypertension.
TetrodotoxinFor the treatment of chronic and breakthrough pain in advanced cancer patients as well as for the treatment of opioid dependence.
TiodazosinTiodazosin is a small molecule drug. Tiodazosin has a monoisotopic molecular weight of 431.14 Da.
TrimetrexateA folate antagonist used for the treatment of moderate-to-severe Pneumocystis carinii pneumonia (PCP) in immunocompromised patients as an alternative therapy in combination with leucovorin.
Drugs & Drug Targets
DrugTargetType
2X-121Poly [ADP-ribose] polymerase tankyrase-1target
2X-121Poly [ADP-ribose] polymerase tankyrase-2target
2X-121Poly [ADP-ribose] polymerase 2target
2X-121Poly [ADP-ribose] polymerase 1target
AfatinibEpidermal growth factor receptortarget
AfatinibReceptor tyrosine-protein kinase erbB-2target
AfatinibReceptor tyrosine-protein kinase erbB-4target
AfatinibATP-dependent translocase ABCB1transporter
AfatinibBroad substrate specificity ATP-binding cassette transporter ABCG2transporter
Altanserin5-hydroxytryptamine receptor 2Atarget
ApabetaloneBromodomain-containing protein 4target
ATH434Alpha-synucleintarget
ATH434Irontarget
ATX-914Extracellular calcium-sensing receptortarget
AvadomideProtein cereblontarget
Butanserin5-hydroxytryptamine 2 receptortarget
ButanserinAlpha-1 adrenergic receptorstarget
Carotegrast methylIntegrin alpha-4target
DacomitinibCytochrome P450 2D6enzyme
DacomitinibAlbumincarrier
DacomitinibCytochrome P450 3A4enzyme
DacomitinibCytochrome P450 2C9enzyme
DacomitinibUDP-glucuronosyltransferase 1A1enzyme
DacomitinibATP-dependent translocase ABCB1transporter
DacomitinibBroad substrate specificity ATP-binding cassette transporter ABCG2transporter
DacomitinibSolute carrier family 22 member 1transporter
DacomitinibEpidermal growth factor receptortarget
DacomitinibReceptor tyrosine-protein kinase erbB-4target
DacomitinibReceptor tyrosine-protein kinase erbB-2target
DoxazosinSolute carrier family 22 member 1transporter
DoxazosinAlpha-1A adrenergic receptortarget
DoxazosinAlpha-1D adrenergic receptortarget
DoxazosinHERG human cardiac K+ channeltarget
DoxazosinATP-dependent translocase ABCB1transporter
DoxazosinCytochrome P450 2C19enzyme
DoxazosinCytochrome P450 2D6enzyme
DoxazosinCytochrome P450 3A4enzyme
DoxazosinAlpha-1B adrenergic receptortarget
DoxazosinCytochrome P450 2C9enzyme
DoxazosinAlpha-1 adrenergic receptorstarget
ElinogrelP2Y purinoceptor 12target
ErlotinibNuclear receptor subfamily 1 group I member 2target
ErlotinibATP-dependent translocase ABCB1transporter
ErlotinibBroad substrate specificity ATP-binding cassette transporter ABCG2transporter
ErlotinibCytochrome P450 3A4enzyme
ErlotinibCytochrome P450 1A1enzyme
ErlotinibCytochrome P450 3A5enzyme
ErlotinibEpidermal growth factor receptorenzyme
ErlotinibSolute carrier organic anion transporter family member 2B1transporter
ErlotinibAlpha-1-acid glycoprotein 1carrier
ErlotinibAlbumincarrier
ErlotinibUDP-glucuronosyltransferase 1A1enzyme
ErlotinibCytochrome P450 2C8enzyme
ErlotinibCytochrome P450 2D6enzyme
ErlotinibCytochrome P450 1B1enzyme
ErlotinibCytochrome P450 1A2enzyme
ErlotinibEpidermal growth factor receptortarget
GefitinibAlpha-1-acid glycoprotein 1carrier
GefitinibAlbumincarrier
GefitinibCytochrome P450 2C19enzyme
GefitinibCytochrome P450 2C9enzyme
GefitinibCytochrome P450 1A1enzyme
GefitinibCytochrome P450 3A5enzyme
GefitinibBroad substrate specificity ATP-binding cassette transporter ABCG2transporter
GefitinibATP-dependent translocase ABCB1transporter
GefitinibCytochrome P450 2D6enzyme
GefitinibCytochrome P450 3A4enzyme
GefitinibEpidermal growth factor receptortarget
HalofuginoneCollagen alpha-1(I) chaintarget
Halofuginone72 kDa type IV collagenasetarget
HalofuginoneBifunctional glutamate/proline--tRNA ligasetarget
IdelalisibATP-dependent translocase ABCB1transporter
IdelalisibAldehyde oxidaseenzyme
IdelalisibCytochrome P450 2C8enzyme
IdelalisibCytochrome P450 2C19enzyme
IdelalisibCytochrome P450 2B6enzyme
IdelalisibCytochrome P450 3A4enzyme
IdelalisibSolute carrier organic anion transporter family member 1B1transporter
IdelalisibSolute carrier organic anion transporter family member 1B3transporter
IdelalisibCytochrome P450 3A5enzyme
IdelalisibCytochrome P450 3A43enzyme
IdelalisibCytochrome P450 3A7enzyme
IdelalisibUDP-glucuronosyltransferase 1A4enzyme
IdelalisibBroad substrate specificity ATP-binding cassette transporter ABCG2transporter
IdelalisibPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformtarget
Ketanserin5-hydroxytryptamine receptor 2Atarget
LapatinibReceptor tyrosine-protein kinase erbB-2target
LapatinibEukaryotic elongation factor 2 kinasetarget
LapatinibCytochrome P450 2C19enzyme
LapatinibCytochrome P450 3A5enzyme
LapatinibAntigen peptide transporter 1transporter
LapatinibATP-dependent translocase ABCB1transporter
LapatinibCytochrome P450 2C8enzyme
LapatinibCytochrome P450 3A4enzyme
LapatinibEpidermal growth factor receptortarget
LinagliptinSolute carrier family 22 member 1transporter
LinagliptinSolute carrier family 22 member 3transporter
LinagliptinATP-dependent translocase ABCB1transporter
LinagliptinCytochrome P450 3A4enzyme
LinagliptinDipeptidyl peptidase 4target
LinagliptinSolute carrier family 22 member 2transporter
MethaqualoneGABA(A) Receptortarget
MethaqualoneCytochrome P450 3A4enzyme
MetolazoneSolute carrier family 12 member 3target
MK-0249Histamine H3 receptortarget
PrazosinAlpha-1A adrenergic receptortarget
PrazosinAlpha-1B adrenergic receptortarget
PrazosinAlpha-1D adrenergic receptortarget
PrazosinVoltage-gated inwardly rectifying potassium channel KCNH2target
PrazosinAlpha-1-acid glycoprotein 1carrier
PrazosinSolute carrier family 22 member 1transporter
PrazosinSolute carrier family 22 member 3transporter
PrazosinATP-dependent translocase ABCB1transporter
PrazosinBroad substrate specificity ATP-binding cassette transporter ABCG2transporter
PrazosinAlpha-2A adrenergic receptortarget
PrazosinAlpha-2B adrenergic receptortarget
PrazosinAlpha-1 adrenergic receptorstarget
SelurampanelGlutamate receptor 2target
SelurampanelKainate receptorstarget
SelurampanelGlutamate receptor 4target
SelurampanelGlutamate receptor 3target
SelurampanelGlutamate receptor 1target
TerazosinTransforming growth factor beta-1 proproteintarget
TerazosinAlpha-1D adrenergic receptortarget
TerazosinATP-dependent translocase ABCB1transporter
TerazosinAlpha-1 adrenergic receptorstarget
TerazosinAlpha-1A adrenergic receptortarget
TerazosinAlpha-1B adrenergic receptortarget
TerazosinVoltage-gated inwardly rectifying potassium channel KCNH7target
TerazosinVoltage-gated inwardly rectifying potassium channel KCNH6target
TerazosinVoltage-gated inwardly rectifying potassium channel KCNH2target
TetrodotoxinSodium channel protein type 2 subunit alphatarget
TetrodotoxinSodium channel protein type 1 subunit alphatarget
TetrodotoxinSodium channel protein type 5 subunit alphatarget
TetrodotoxinSodium channel protein type 8 subunit alphatarget
TetrodotoxinSodium channel protein type 3 subunit alphatarget
TrimetrexateDihydrofolate reductasetarget
TrimetrexatePeptide deformylase, mitochondrialtarget
TrimetrexateDihydrofolate reductasetarget
TrimetrexateReduced folate transportertransporter